Acylated Cholesteryl Galactosides Are Specific Antigens of Borrelia Causing Lyme Disease and Frequently Induce Antibodies in Late Stages of Disease
暂无分享,去创建一个
U. Göbel | R. Schumann | U. Zähringer | V. Fingerle | B. Wilske | N. Schröder | Gunthard Stübs | N. W. Schröder
[1] F. Strle,et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. , 2008, International journal of medical microbiology : IJMM.
[2] S. Bergström,et al. Functional analysis of a lipid galactosyltransferase synthesizing the major envelope lipid in the Lyme disease spirochete Borrelia burgdorferi. , 2007, FEMS microbiology letters.
[3] V. Fingerle,et al. Microbiological and serological diagnosis of Lyme borreliosis. , 2007, FEMS immunology and medical microbiology.
[4] H. Mollenkopf,et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori , 2006, Nature Medicine.
[5] I. Wilson,et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria , 2006, Nature Immunology.
[6] K. Thompson,et al. The Lyme vaccine: a cautionary tale , 2006, Epidemiology and Infection.
[7] V. Fingerle,et al. Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues , 2005, Journal of Clinical Microbiology.
[8] A. Steere,et al. The emergence of Lyme disease. , 2004, The Journal of clinical investigation.
[9] Robert P. Smith. Lyme Borreliosis: Biology, Epidemiology, and Control , 2003 .
[10] U. Göbel,et al. Acylated Cholesteryl Galactoside as a Novel Immunogenic Motif in Borrelia burgdorferi Sensu Stricto* , 2003, Journal of Biological Chemistry.
[11] A. Steere,et al. The presenting manifestations of Lyme disease and the outcomes of treatment. , 2003, The New England journal of medicine.
[12] B. Coxon,et al. A newly discovered cholesteryl galactoside from Borrelia burgdorferi , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Rottem. Sterols and acylated proteins in mycoplasmas. , 2002, Biochemical and biophysical research communications.
[14] A. Steere,et al. Clinical Characteristics and Treatment Outcome of Early Lyme Disease in Patients with Microbiologically Confirmed Erythema Migrans , 2002, Annals of Internal Medicine.
[15] K. Reed. Laboratory Testing for Lyme Disease: Possibilities and Practicalities , 2002, Journal of Clinical Microbiology.
[16] H. Hossain,et al. Structural analysis of glycolipids from Borrelia burgdorferi. , 2001, Biochimie.
[17] H. Karch,et al. Incidence of Lyme Borreliosis in the Würzburg Region of Germany , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[18] T. Zank,et al. Cloning and Functional Expression of UGT Genes Encoding Sterol Glucosyltransferases from Saccharomyces cerevisiae, Candida albicans, Pichia pastoris, andDictyostelium discoideum * , 1999, The Journal of Biological Chemistry.
[19] A. Steere,et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.
[20] C. Schmid,et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. , 1998, The New England journal of medicine.
[21] V. Fingerle,et al. Impact of Strain Heterogeneity on Lyme Disease Serology in Europe: Comparison of Enzyme-Linked Immunosorbent Assays Using Different Species of Borrelia burgdorferi Sensu Lato , 1998, Journal of Clinical Microbiology.
[22] S. Salzberg,et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi , 1997, Nature.
[23] Z. Hubálek,et al. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review , 1997, European Journal of Epidemiology.
[24] I. Yano,et al. Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature , 1996, Journal of bacteriology.
[25] V. Fingerle,et al. Immunological and molecular variability of OspA and OspC. implications forBorrelia vaccine development , 1996, Infection.
[26] Takashi Yoshida,et al. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis , 1995, Journal of bacteriology.
[27] Jeffrey D. Jones,et al. Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease spirochete , 1995, Infection and immunity.
[28] T. Taki,et al. Blotting of glycolipids and phospholipids from a high-performance thin-layer chromatogram to a polyvinylidene difluoride membrane. , 1994, Analytical biochemistry.
[29] U. Schaible,et al. A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. , 1994, Immunology.
[30] J. Radolf,et al. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins , 1994, Journal of bacteriology.
[31] A. Steere,et al. The clinical evolution of Lyme arthritis. , 1987, Annals of internal medicine.
[32] J. P. Davis,et al. Lyme disease: A tick-borne spirochetosis , 1983 .
[33] R. C. Johnson,et al. Lipid metabolism of Borrelia hermsi , 1978, Infection and immunity.
[34] R. C. Johnson,et al. Lipids of the Spirochaetales: Comparison of the Lipids of Several Members of the Genera Spirochaeta, Treponema, and Leptospira , 1974, Journal of bacteriology.
[35] P. F. Smith. Biosynthesis of Cholesteryl Glucoside by Mycoplasma gallinarum , 1971, Journal of bacteriology.
[36] J. Steim. Monogalactosyl diglyceride: a new neurolipid. , 1967, Biochimica et biophysica acta.
[37] Z. Hubálek. Epidemiology of lyme borreliosis. , 2009, Current problems in dermatology.
[38] T. Jaenson. The epidemiology of lyme borreliosis. , 1991, Parasitology today.